Firm
The firm reported a small uptick in overall revenue and profit per equity partner, while its IP team secured notable life sciences victories
Paul Ainsworth, who secured a settlement for his client in a patent dispute, says the case shows why medical claims by dietary supplement companies can threaten IP rights
Boies Schiller Flexner joins forces with Grünecker to target Skechers in Europe following US lawsuit
Helen Mutimer discusses how the firm’s IP advisory services are filling a gap in the market, and why life sciences work is soaring
Sponsored
Sponsored
-
Sponsored by CASCAS explains how intellectual property (IP) is becoming increasingly central to companies, particularly to research and development (R&D) teams, and highlights five key findings from a survey of senior business leaders -
Sponsored by Shiga International Patent OfficeManabu Goto of Shiga International Patent Office explains why restrictions on multi-multi claims have been introduced by the Japan Patent Office and offers advice to Japanese and overseas patent applicants
-
Sponsored by FirstLaw PCKorean pharmaceutical patentees should be encouraged by the Supreme Court’s change of stance regarding selection inventions and crystalline form inventions, report Won Sang Lee and Hyung Eun Cho of FirstLaw P.C.
-
Sponsored by Anand and AnandDhruv Anand and Udita M Patro of Anand and Anand explain the significance of a recent ruling concerning trademark protection of film titles and assess the tests used to establish the copyrightability of characters
-
Sponsored by Adams & AdamsAlissa Naran and Nicole Smalberger of Adams & Adams explain the latest developments on protecting trademarks in Africa, in the first of a three-part podcast series
-
Sponsored by Gün and PartnersSelin Sinem Erciyas and Aysel Korkmaz Yatkın of Gün + Partners explain the significance of a ruling in Turkey on the validity of second medical use patents granted by the European Patent Office
